Search / 277 results found

  • Updated

PORTLAND, Ore., Oct. 18, 2021 /PRNewswire-PRWeb/ -- Today, Owl announced that Recovery Centers of America (RCA), a leading national provider of evidence-based addiction treatment, has selected Owl's measurement-based care (MBC) platform to enable enhanced care and measurable clinical outcomes for RCA patients. RCA will implement Owl across its ten inpatient substance use disorder treatment facilities in six states, many of which have been ranked among the top-rated treatment programs in the U.S. according to Newsweek Magazine.

  • Updated

LAKE OSWEGO, Ore., Sept. 29, 2021 /PRNewswire/ -- BIOTRONIK announced today it received U.S. Food and Drug Administration (FDA) approval of its Orsiro® Mission bioabsorbable polymer drug-eluting stent system (BP-DES). The company also announced the first U.S. implant and full commercial launch of the new DES system, which offers advanced deliverability and an ultrathin strut design considered the thinnest available in the United States.